NXS 0.00% 27.0¢ next science limited

talk of a raising is rubbish as i see it

  1. 3,849 Posts.
    All this talk of a raising that the Co. appears to have largely discounted is playing into the hands of those who look a little longer term and are probably driving some of this SP volatility.

    The only way there would be a raising that I can envisage would involve the AED deal falling over. Now if I was a shareholder of NXS I'd assume with Puffin seemingly locked down and AED/SINOPEC on the prowl for production any issues with the deal would likely only occur if NXS killed it, hence making themselves an even bigger target for a straight TO.

    Likewise any raising that allowed the AED deal to "fallover" would only be advantageous to NXS allowing them to keep 100% of LT production thereby not seeing 50% sold at the capital replacement value and doubling short term cashflow reducing debt issues etc.

    Either way NXS benefits and hence so do the shareholders.
    After the escape the Co has made from the GFC why would it now dilute?

    BTW buyers once again queue near the bottom of the range.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.